197 related articles for article (PubMed ID: 3367303)
1. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
Cherian MG; Miles EF; Clarkson TW; Cox C
J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
[TBL] [Abstract][Full Text] [Related]
2. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
3. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.
Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Aposhian MM; Dart RC; Woods JS; Ostrosky-Wegman P; Gonsebatt ME; Aposhian HV
J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576
[TBL] [Abstract][Full Text] [Related]
4. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
Diamond GL; Klotzbach JM; Stewart JR
J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
[TBL] [Abstract][Full Text] [Related]
5. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV
J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
[TBL] [Abstract][Full Text] [Related]
6. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D
J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341
[TBL] [Abstract][Full Text] [Related]
7. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
[TBL] [Abstract][Full Text] [Related]
10. Chelation in metal intoxication. XX: Effect of pre-treatment with chelators on the distribution of mercury.
Kachru DN; Tandon SK
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):399-402. PubMed ID: 3016847
[TBL] [Abstract][Full Text] [Related]
11. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
Zalups RK; Gelein RM; Cernichiari E
J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
[TBL] [Abstract][Full Text] [Related]
12. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age.
Kostial K; Kargacin B; Blanusa M; Landeka M
Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703
[TBL] [Abstract][Full Text] [Related]
13. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use.
Twarog T; Cherian MG
Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504
[TBL] [Abstract][Full Text] [Related]
14. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate.
Gabard B; Walser R
J Toxicol Environ Health; 1979 Jul; 5(4):759-64. PubMed ID: 490684
[TBL] [Abstract][Full Text] [Related]
15. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.
Klotzbach JM; Diamond GL
Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889
[TBL] [Abstract][Full Text] [Related]
16. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors.
Buchet JP; Lauwerys RR
Toxicology; 1989 Mar; 54(3):323-33. PubMed ID: 2539660
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Dimercaptopropane-1-sodium sulfonate for reducing retention of ingested 203Hg in suckling rats.
Kostial K; Kargacin B; Landeka M
Bull Environ Contam Toxicol; 1988 Aug; 41(2):185-8. PubMed ID: 3207899
[No Abstract] [Full Text] [Related]
18. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
Chisolm JJ; Thomas DJ
J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
[TBL] [Abstract][Full Text] [Related]
20. Effect of mercuric chloride on urinary excretion of free hydroxyproline.
Siddiqi NJ; Alhomida AS
Med Sci Monit; 2006 Mar; 12(3):BR95-101. PubMed ID: 16501418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
